Related Experiment Video
Updated: Feb 5, 2026

In vitro Assembly of Semi-artificial Molecular Machine and its Use for Detection of DNA Damage
Published on: January 11, 2012
Damage-Associated Molecular Patterns in Inflammatory Diseases
Jong Seong Roh1, Dong Hyun Sohn1
1Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan 50612, Korea.
Abstract:
Damage-associated molecular patterns (DAMPs) are endogenous danger molecules that are released from damaged or dying cells and activate the innate immune system by interacting with pattern recognition receptors (PRRs). Although DAMPs contribute to the host's defense, they promote pathological inflammatory responses. Recent studies have suggested that various DAMPs, such as high-mobility group box 1 (HMGB1), S100 proteins, and heat shock proteins (HSPs), are increased and considered to have a pathogenic role in inflammatory diseases. Here, we review current research on the role of DAMPs in inflammatory diseases, including rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, atherosclerosis, Alzheimer's disease, Parkinson's disease, and cancer. We also discuss the possibility of DAMPs as biomarkers and therapeutic targets for these diseases.
Insights
Damage-associated molecular patterns (DAMPs) are released from damaged cells and activate immune responses. This review explores their pathogenic role in diseases like arthritis, Alzheimer's, and cancer, highlighting DAMPs as potential biomarkers and therapeutic targets.
Area of Science:
- Immunology
- Molecular Biology
- Pathology
Background:
- Damage-associated molecular patterns (DAMPs) are endogenous molecules released from stressed or necrotic cells.
- DAMPs interact with pattern recognition receptors (PRRs), activating innate immune responses.
- While crucial for host defense, DAMPs can also drive pathological inflammation.
Purpose of the Study:
- To review the current understanding of DAMPs' roles in various inflammatory diseases.
- To explore the involvement of specific DAMPs like HMGB1, S100 proteins, and HSPs.
- To discuss the potential of DAMPs as diagnostic biomarkers and therapeutic targets.
Main Methods:
- Literature review of recent research on DAMPs and inflammatory diseases.
- Analysis of studies investigating HMGB1, S100 proteins, and HSPs.
- Examination of evidence linking DAMPs to specific conditions such as rheumatoid arthritis, lupus, osteoarthritis, atherosclerosis, Alzheimer's, Parkinson's, and cancer.
Main Results:
- DAMPs are implicated in the pathogenesis of numerous inflammatory and neurodegenerative diseases.
- Elevated levels of specific DAMPs (HMGB1, S100, HSPs) are observed in affected patients.
- DAMPs contribute to chronic inflammation and tissue damage in conditions like arthritis and atherosclerosis.
- DAMPs are increasingly recognized for their role in neuroinflammation in Alzheimer's and Parkinson's disease.
- DAMPs are also implicated in cancer development and progression.
Conclusions:
- DAMPs play a significant dual role in immunity, contributing to both defense and disease.
- Targeting DAMPs offers a promising therapeutic strategy for a range of inflammatory and chronic diseases.
- DAMPs hold potential as valuable biomarkers for early diagnosis and disease monitoring.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...